| David F Moore, MD | |
|
99-840 Iwaiwa St, Aiea, HI 96701-3280 | |
| (808) 828-0202 | |
| Not Available |
| Full Name | David F Moore |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 99-840 Iwaiwa St, Aiea, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215015912 | NPI | - | NPPES |
| MD 3962 | Other | HI | MD LICENSE |
| 00G428080 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G42808 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David F Moore, MD 99-840 Iwaiwa St, Aiea, HI 96701-3280 Ph: (808) 828-0202 | David F Moore, MD 99-840 Iwaiwa St, Aiea, HI 96701-3280 Ph: (808) 828-0202 |
News Archive
Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.
The Association of Faculties of Medicine of Canada (AFMC), along with other organizations in Canada including the Multiple Sclerosis Society of Canada and the Canadian Institutes for Health Research, is in strong support of rigorous scientific research to determine the possible link between blood vessel anomalies and multiple sclerosis and the potential benefits of surgical intervention to relieve its symptoms.
InVivo Therapeutics Corporation CEO Frank Reynolds will be honored by the Irish Voice and Irish America Magazine, in collaboration with the Irish Government, as one of the 'Irish Life Science 50.' The award is the first honor to be given to influential Irish Americans for their work in the field of life sciences and is aimed to recognize "diverse accomplishments and advancements in the industry," according the Irish Voice.
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that clinical investigators have enrolled the first patient in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment of epithelial ovarian cancer, the most lethal form of gynecological cancer.
› Verified 4 days ago
Robert Canonico, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 330-493-4443 | |
Dr. Joseph D. Lewis Iv, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-777 Lanikuakaa St, Aiea, HI 96701 Phone: 808-484-9109 Fax: 808-485-1976 | |
Dr. Alan L Chang, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Emergency Department, Pali Momi Medical Center, Aiea, HI 96701 Phone: 808-485-4300 | |
Jason Fleming, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-485-4300 Fax: 808-485-4300 | |
Dinora Gil, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 330-493-4443 | |
Dr. Jermaine Robertson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 |